v3.24.3

Stockholders' Equity - Warrants (Details) - USD ($) |  |  |  |  |  |  |  | 3 Months Ended | 12 Months Ended |  |
--- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | ---
Apr. 01, 2024 | Mar. 26, 2024 | Mar. 25, 2024 | Dec. 07, 2023 | Dec. 09, 2022 | Dec. 06, 2022 | Nov. 01, 2021 | Sep. 30, 2024 | Jun. 30, 2024 | Jun. 30, 2023 | Aug. 04, 2023 | Aug. 03, 2023
Cantor Fitzgerald Underwriting | At-The-Market Offerings | Common Stock |  |  |  |  |  |  |  |  |  |  |  |
Class of Stock [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Common stock, shares issued |  |  |  |  |  |  |  | 170,989 | 289,144 |  |  |
Wainwright Underwriting | At-The-Market Offerings | Common Stock |  |  |  |  |  |  |  |  |  |  |  |
Class of Stock [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Common stock, shares issued |  |  |  |  |  | 76,538 |  |  |  |  |  |
Wainwright Underwriting | At-The-Market Offerings | Common Stock | Pre-Funded Warrants |  |  |  |  |  |  |  |  |  |  |  |
Class of Stock [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Warrants, shares issued |  |  |  |  |  | 91,730 |  |  |  |  |  |
Wainwright Underwriting | At-The-Market Offerings | Common Stock | Series A warrants |  |  |  |  |  |  |  |  |  |  |  |
Class of Stock [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Warrants, shares issued |  |  |  |  |  | 168,269 |  |  |  |  |  |
Wainwright Underwriting | At-The-Market Offerings | Common Stock | Series B warrants |  |  |  |  |  |  |  |  |  |  |  |
Class of Stock [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Warrants, shares issued |  |  |  |  |  | 168,269 |  |  |  |  |  |
Wainwright Underwriting | H.C. Wainwright & Co. | Underwriters Option | Common Stock | Maximum |  |  |  |  |  |  |  |  |  |  |  |
Class of Stock [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Warrants, shares issued |  |  |  |  | 50,480 |  |  |  |  |  |  |
Wainwright Underwriting | H.C. Wainwright & Co. | Underwriters Option | Common Stock | Minimum |  |  |  |  |  |  |  |  |  |  |  |
Class of Stock [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Warrants, shares issued |  |  |  |  | 25,240 |  |  |  |  |  |  |
Wainwright Underwriting | H.C. Wainwright & Co. | Underwriters Option | Common Stock | Representative Warrants |  |  |  |  |  |  |  |  |  |  |  |
Class of Stock [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Warrants, shares issued |  |  |  |  | 10,094 |  |  |  |  |  |  |
Wainwright Underwriting | H.C. Wainwright & Co. | Underwriters Option | Common Stock | Series A warrants |  |  |  |  |  |  |  |  |  |  |  |
Class of Stock [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Warrants, shares issued |  |  |  |  | 25,240 |  |  |  |  |  |  |
Wainwright Underwriting | H.C. Wainwright & Co. | Underwriters Option | Common Stock | Series B warrants |  |  |  |  |  |  |  |  |  |  |  |
Class of Stock [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Warrants, shares issued |  |  |  |  | 25,240 |  |  |  |  |  |  |
Lincoln Park Stock Purchase Agreement | At-The-Market Offerings | Common Stock |  |  |  |  |  |  |  |  |  |  |  |
Class of Stock [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Common stock, shares issued |  |  |  |  |  |  |  |  | 202,595 |  |  |
Securities Purchase Agreement | Alliance Global Partners | Private placement |  |  |  |  |  |  |  |  |  |  |  |
Class of Stock [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Combined price per share of common stock and warrants |  |  |  | $ 2.00 |  |  |  |  |  |  |  |
Securities Purchase Agreement | Alliance Global Partners | Private placement | Common Stock |  |  |  |  |  |  |  |  |  |  |  |
Class of Stock [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Common stock, shares issued |  |  |  | 600,000 |  |  |  |  |  |  |  |
Securities Purchase Agreement | Alliance Global Partners | Private placement | Common Stock | Pre-Funded Warrants |  |  |  |  |  |  |  |  |  |  |  |
Class of Stock [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Warrants, shares issued |  |  |  | 1,650,000 |  |  |  |  |  |  |  |
Warrants, shares of common stock issuable upon conversion |  |  |  | 1,650,000 |  |  |  |  |  |  |  |
Securities Purchase Agreement | Alliance Global Partners | Private placement | Common Stock | Series C Warrants |  |  |  |  |  |  |  |  |  |  |  |
Class of Stock [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Warrants, shares issued |  |  |  | 2,250,000 |  |  |  |  |  |  |  |
Warrants, shares of common stock issuable upon conversion |  |  |  | 2,250,000 |  |  |  |  |  |  |  |
Securities Purchase Agreement | Alliance Global Partners | Private placement | Common Stock | Series D Warrants |  |  |  |  |  |  |  |  |  |  |  |
Class of Stock [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Warrants, shares issued |  |  |  | 2,250,000 |  |  |  |  |  |  |  |
Warrants, shares of common stock issuable upon conversion |  |  |  | 2,250,000 |  |  |  |  |  |  |  |
Securities Purchase Agreement and Warrants | Private placement | Common Stock |  |  |  |  |  |  |  |  |  |  |  |
Class of Stock [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Common stock, shares issued |  | 2,701,315 |  |  |  |  |  |  |  |  |  |
Securities Purchase Agreement and Warrants | Private placement | Common Stock | Pre-Funded Warrants |  |  |  |  |  |  |  |  |  |  |  |
Class of Stock [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Warrants, shares issued |  | 2,585,963 |  |  |  |  |  |  |  |  |  |
Warrants, exercise price |  | $ 0.0001 |  |  |  |  |  |  |  |  |  |
Securities Purchase Agreement and Warrants | Private placement | Common Stock | Series E Warrants |  |  |  |  |  |  |  |  |  |  |  |
Class of Stock [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Warrants, shares issued |  | 5,287,278 |  |  |  |  |  |  |  |  |  |
Warrants, exercise price |  | $ 2.64 |  |  |  |  |  |  |  |  |  |
Warrants, exercisable term |  | 5 years |  |  |  |  |  |  |  |  |  |
Securities Purchase Agreement and Warrants | Private placement | Common Stock | Common Shares and Series E Warrants |  |  |  |  |  |  |  |  |  |  |  |
Class of Stock [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Combined price per share of common stock and warrants |  | $ 2.85 |  |  |  |  |  |  |  |  |  |
Securities Purchase Agreement and Warrants | Private placement | Common Stock | Pre-funded and Series E Warrants |  |  |  |  |  |  |  |  |  |  |  |
Class of Stock [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Combined price per share of common stock and warrants |  | $ 2.849 |  |  |  |  |  |  |  |  |  |
Securities Purchase Agreement and Warrants | Private placement | Common Stock | Pre-funded and Series E Warrants | Maximum |  |  |  |  |  |  |  |  |  |  |  |
Class of Stock [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Warrant exercise, common stock ownership limitation |  | 4.99% |  |  |  |  |  |  |  |  |  |
Warrant exercise, common stock ownership limitation (at the election of the holder) |  | 9.99% | 9.99% |  |  |  |  |  |  |  |  |
Securities Purchase Agreement and Warrants | Private placement | Common Stock | Pre-funded and Series E Warrants | Minimum |  |  |  |  |  |  |  |  |  |  |  |
Class of Stock [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Warrant holder's election, period of written notice |  | 61 days |  |  |  |  |  |  |  |  |  |
Warrants | H.C. Wainwright & Co. | Common Stock | Pre-Funded Warrants |  |  |  |  |  |  |  |  |  |  |  |
Class of Stock [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Warrants, exercise price |  |  |  |  |  |  |  |  |  |  |  | $ 0.001
Warrants | H.C. Wainwright & Co. | Common Stock | Representative Warrants |  |  |  |  |  |  |  |  |  |  |  |
Class of Stock [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Warrants, exercise price |  |  |  |  |  |  |  |  |  |  |  | $ 26.00
Warrants, exercisable term |  |  |  |  |  |  |  |  |  |  |  | 5 years
Warrants | H.C. Wainwright & Co. | Common Stock | Warrants |  |  |  |  |  |  |  |  |  |  |  |
Class of Stock [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Warrants, exercise price |  |  |  |  |  |  |  |  |  |  | $ 10.00 | $ 20.80
Warrants, shares exercised |  |  |  |  |  |  |  |  | 0 |  |  |
Proceeds from exercise of warrants |  |  |  |  |  |  |  |  |  | $ 2,207,000 |  |
Warrants, shares of common stock issuable upon conversion |  |  |  |  |  |  |  | 0 |  |  |  |
Warrants | H.C. Wainwright & Co. | Common Stock | Series A warrants |  |  |  |  |  |  |  |  |  |  |  |
Class of Stock [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Warrants, exercise price |  |  |  |  |  |  |  |  |  |  |  | $ 20.80
Warrants, exercisable term |  |  |  |  |  |  |  |  |  |  |  | 5 years
Warrants, shares exercised |  |  |  |  |  |  |  |  |  | 17,064 |  |
Warrants, shares of common stock issuable upon conversion |  |  |  |  |  |  |  |  |  |  | 173,795 |
Warrants | H.C. Wainwright & Co. | Common Stock | Series B warrants |  |  |  |  |  |  |  |  |  |  |  |
Class of Stock [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Warrants, exercise price |  |  |  |  |  |  |  |  |  |  |  | $ 20.80
Warrants, exercisable term |  |  |  |  |  |  |  |  |  |  |  | 2 years
Warrants, shares exercised |  |  |  |  |  |  |  |  |  | 89,059 |  |
Warrants, shares of common stock issuable upon conversion |  |  |  |  |  |  |  |  |  |  | 102,900 |
Warrants | Bryan Capital | Common Stock | Warrants |  |  |  |  |  |  |  |  |  |  |  |
Class of Stock [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Warrants, shares issued |  |  |  |  |  |  | 2,579 |  |  |  |  |
Warrants, exercise price |  |  |  |  |  |  | $ 665 |  |  |  |  |
Warrants | Alliance Global Partners | Private placement | Common Stock |  |  |  |  |  |  |  |  |  |  |  |
Class of Stock [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Common stock, shares issued |  |  |  | 600,000 |  |  |  |  |  |  |  |
Warrants | Alliance Global Partners | Private placement | Common Stock | Pre-Funded Warrants |  |  |  |  |  |  |  |  |  |  |  |
Class of Stock [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Warrants, shares issued |  |  |  | 1,650,000 |  |  |  |  |  |  |  |
Warrants, exercise price |  |  |  | $ 0.0001 |  |  |  |  |  |  |  |
Warrants, shares exercised |  |  |  |  |  |  |  |  | 1,650,000 |  |  |
Warrants, shares of common stock issuable upon conversion |  |  |  | 1,650,000 |  |  |  |  |  |  |  |
Warrants | Alliance Global Partners | Private placement | Common Stock | Warrants |  |  |  |  |  |  |  |  |  |  |  |
Class of Stock [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Warrants, exercise price |  |  |  | $ 1.9999 |  |  |  |  |  |  |  |
Proceeds from exercise of warrants |  |  |  |  |  |  |  | $ 4,000 | $ 4,464,000 |  |  |
Warrants | Alliance Global Partners | Private placement | Common Stock | Series C Warrants |  |  |  |  |  |  |  |  |  |  |  |
Class of Stock [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Warrants, shares issued |  |  |  | 2,250,000 |  |  |  |  |  |  |  |
Warrants, exercise price |  |  |  | $ 2.00 |  |  |  |  |  |  |  |
Warrants, exercisable term |  |  |  | 2 years |  |  |  |  |  |  |  |
Warrants, shares exercised |  |  |  |  |  |  |  | 1,000 | 1,178,500 |  |  |
Warrants, shares of common stock issuable upon conversion |  |  |  | 2,250,000 |  |  |  |  |  |  |  |
Warrants | Alliance Global Partners | Private placement | Common Stock | Series D Warrants |  |  |  |  |  |  |  |  |  |  |  |
Class of Stock [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Warrants, shares issued |  |  |  | 2,250,000 |  |  |  |  |  |  |  |
Warrants, exercise price |  |  |  | $ 2.00 |  |  |  |  |  |  |  |
Warrants, exercisable term |  |  |  | 5 years |  |  |  |  |  |  |  |
Warrants, shares exercised |  |  |  |  |  |  |  | 1,000 | 1,053,500 |  |  |
Warrants, shares of common stock issuable upon conversion |  |  |  | 2,250,000 |  |  |  |  |  |  |  |
Warrants | Chardan Capital Markets | Private placement | Common Stock |  |  |  |  |  |  |  |  |  |  |  |
Class of Stock [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Warrants, shares issued | 2,701,315 |  |  |  |  |  |  |  |  |  |  |
Warrants | Chardan Capital Markets | Private placement | Common Stock | Pre-Funded Warrants |  |  |  |  |  |  |  |  |  |  |  |
Class of Stock [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Warrants, exercise price | $ 0.0001 |  |  |  |  |  |  |  |  |  |  |
Warrants, shares exercised | 2,585,963 |  |  |  |  |  |  |  |  |  |  |
Warrants | Chardan Capital Markets | Private placement | Common Stock | Series E Warrants |  |  |  |  |  |  |  |  |  |  |  |
Class of Stock [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Warrants, shares issued | 5,287,278 |  |  |  |  |  |  |  |  |  |  |
Warrants, exercise price | $ 2.64 |  |  |  |  |  |  |  |  |  |  |
Warrants, exercisable term | 5 years |  |  |  |  |  |  |  |  |  |  |
Warrants, shares exercised |  |  |  |  |  |  |  | 0 |  |  |  |
Warrants | Chardan Capital Markets | Private placement | Common Stock | Common Shares and Series E Warrants |  |  |  |  |  |  |  |  |  |  |  |
Class of Stock [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Combined price per share of common stock and warrants | $ 2.85 |  |  |  |  |  |  |  |  |  |  |
Warrants | Chardan Capital Markets | Private placement | Common Stock | Pre-funded and Series E Warrants |  |  |  |  |  |  |  |  |  |  |  |
Class of Stock [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Combined price per share of common stock and warrants | $ 2.849 |  |  |  |  |  |  |  |  |  |  |

X
- Definition The effective ownership of the outstanding shares of the Company's common stock immediately after exercise of warrants - threshold percentage for which warrant holders may not exceed. + References No definition available. + Details
Name: | ibio_OwnershipThresholdPercentage
Namespace Prefix: | ibio_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition The effective ownership of the outstanding shares of the Company's common stock, with written notice given by the holder to the Company, immediately after exercise of warrants - threshold percentage for which warrant holders may not exceed. + References No definition available. + Details
Name: | ibio_OwnershipThresholdPercentageElectionOfHolder
Namespace Prefix: | ibio_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Minimum days of prior written notice needed to satisfy the holder's election to exercise warrants that give the holder, together with affiliates, a beneficial ownership in the Company's common stock of not more than 9.99%. + References No definition available. + Details
Name: | ibio_WarrantExercisesOwnershipLimitationTermOfWrittenNotice
Namespace Prefix: | ibio_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13 Reference 2: http://www.xbrl.org/2003/role/recommendedDisclosureRef -Topic 272 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483014/272-10-45-3 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 272 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482987/272-10-50-1 Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(d)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (e) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (h) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 14 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 18 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(27)(b)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(28)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-03(i)(2)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3 Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-03(i)(1)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3 Reference 17: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-03(i)(2)(i)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3 Reference 18: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-03(i)(2)(ii)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3 + Details
Name: | us-gaap_ClassOfStockLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Exercise price per share or per unit of warrants or rights outstanding. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3 + Details
Name: | us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares. + References No definition available. + Details
Name: | us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3 + Details
Name: | us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition The number of warrants issued as [noncash or part noncash] consideration for a business or asset acquired. Noncash is defined as transactions during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 4 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482913/230-10-50-4 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 5 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5 + Details
Name: | us-gaap_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationWarrantsIssued1
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition The cash inflow associated with the amount received from holders exercising their stock warrants. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 230 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 14 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14 + Details
Name: | us-gaap_ProceedsFromWarrantExercises
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The number of shares issued or sold by the subsidiary or equity method investee per stock transaction. + References No definition available. + Details
Name: | us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Price of a single share of a number of saleable stocks of a company. + References No definition available. + Details
Name: | us-gaap_SharePrice
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (bbb)(2)(i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (bbb)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (bbb)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 + Details
Name: | us-gaap_WarrantsAndRightsOutstandingTerm
Namespace Prefix: | us-gaap_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | instant

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=ibio_CantorFitzgeraldUnderwritingAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=ibio_AtMarketOfferingsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=ibio_WainwrightUnderwritingAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=ibio_PreFundedWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=ibio_SeriesWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=ibio_SeriesBWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_CounterpartyNameAxis=ibio_HcWainwrightAndCompanyLlcMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MaximumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MinimumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=ibio_RepresentativeWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=ibio_LincolnParkStockPurchaseAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=ibio_SecuritiesPurchaseAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_CounterpartyNameAxis=ibio_AllianceGlobalPartnersMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=ibio_SeriesCWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=ibio_SeriesDWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=ibio_SecuritiesPurchaseStockAndWarrantsAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=ibio_SeriesEWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=ibio_CommonStockAndSeriesEWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=ibio_PreFundedWarrantsAndSeriesEWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=ibio_WarrantAgreementsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=ibio_CommonStockWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_CounterpartyNameAxis=ibio_BryanCapitalMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_CounterpartyNameAxis=ibio_ChardanCapitalMarketsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |